We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot

By HospiMedica International staff writers
Posted on 15 May 2024

Scientists have ingeniously combined biomedical expertise with nature-inspired engineering to develop a jelly-like material that holds significant promise for immediate repairs to a wide variety of damaged organs and tissues in the human body. More...

This groundbreaking research could potentially transform millions of lives through the use of peptide-based hydrogels, which are designed to seal skin wounds, administer therapeutic agents to injured heart muscle, and aid in the reshaping and healing of damaged corneas.

Peptides are organic molecules found in living organisms, while hydrogels are water-based, gelatinous substances that have already shown their utility in therapeutic applications. Unlike most hydrogels used in tissue engineering, which are derived from animal sources and protein-based, the biomaterial developed by the collaborative effort from the University of Ottawa (Ontario, Canada) incorporates specially engineered peptides, enhancing its clinical applicability. The key to their utility lies in their modifiability; the hydrogels from the uOttawa team are designed to be highly customizable. This robust material can be tailored for different tissue needs by adjusting its adhesiveness or altering other properties to suit specific repair needs within the body.

According to the researchers, not only do their findings indicate that the hydrogels are highly effective for therapeutic use, but their application is also simpler and more cost-effective than other regenerative methods. Engineered to be both low-cost and scalable, these materials possess critical attributes for widespread biomedical use. Additionally, the team has developed a rapid screening protocol that drastically cuts both the costs of design and the duration of testing. Moving forward, the research group plans to undertake large animal studies in preparation for human trials. Preliminary tests have been performed on the heart and skin using rodent models, and corneal tests have been conducted ex vivo.

“We are using peptides to fabricate therapeutic solutions. The team is drawing inspiration from nature to develop simple solutions for wound closure and tissue repair,” said uOttawa Faculty of Medicine Associate Professor Dr. Emilio I. Alarcón. “We were in fact very surprised by the range of applications our materials can achieve. Our technology offers an integrated solution that is customizable depending on the targeted tissue.”

Related Links:
University of Ottawa


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.